REVELATION BIOSCIENCES, INC. (REVB)
About REVELATION BIOSCIENCES, INC.
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$8.9M
- Total assets
- $11.6M
- Market cap
- $3.9M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $9.1M
- Operating income
- -$9.1M
- Income tax
- $0
- Net income
- -$8.9M
- EPS (basic)
- $-23.95
- EPS (diluted)
- $-23.95
Balance sheet
- Total assets
- $11.6M
- Current assets
- $10.8M
- Total liabilities
- $2.7M
- Current liabilities
- $2.0M
- Shareholders’ equity
- $8.9M
Cash flow
- Operating cash flow
- -$8.3M
- Investing cash flow
- -$4.2M
- Financing cash flow
- $12.5M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $3.9M
- EPS (diluted)
- $-23.95
- Shares outstanding
- 3.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 11, 2022
Revelation Biosciences, Inc. (REVB) Stock Price
- Reported a net loss of $8.9M.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review REVELATION BIOSCIENCES, INC..
Write a review
News about REVELATION BIOSCIENCES, INC.
News & sentiment via Polygon.io
Revelation Biosciences, Inc.: frequently asked questions
Is Revelation Biosciences, Inc. an American company?
Revelation Biosciences, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Revelation Biosciences, Inc. headquartered?
Revelation Biosciences, Inc. is headquartered in San Diego, California, United States.
Is Revelation Biosciences, Inc. publicly traded?
Yes — Revelation Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol REVB on the NASDAQ.
What does Revelation Biosciences, Inc. do?
Revelation Biosciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
